ArticleNeuro-oncology advances

Prediction of progression-free and overall survival following temozolomide chemoradiation using FET PET-based parameters including radiomics in patients with glioblastoma.

Isabelle Stetter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.